In such cases, HS1/cortactin binds to the SH3-binding site, which is dependent upon the proline at position 841 of ROR1, and activates RhoA to enhance the migration-capacity of CLL cells. This evidence concerns the gene RHOA and B-cell chronic lymphocytic leukemia.